Search

Search Constraints

You searched for: Author/Creator O'Byrne, Sharon

Search Results

1. A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis. Issue 8 (20th June 2012)

3. Etrolizumab Treatment Increases Blood Levels of CD3, Treg, and Th17 Cells Measured Through Epigenetic Activation of CD3, FoxP3 and IL‐17 Loci: 1829. (October 2015)

7. Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis. Issue 6 (25th October 2018)

8. Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis. Issue 6 (4th May 2019)

10. ΑEβ7 Integrin Identifies Subsets of Pro-Inflammatory Colonic CD4+ T Lymphocytes in Ulcerative Colitis. (7th December 2016)